Literature DB >> 11247764

Regulation of B(2)-kinin receptors by glucose in vascular smooth muscle cells.

J Christopher1, V Velarde, D Zhang, D Mayfield, R K Mayfield, A A Jaffa.   

Abstract

The development of vascular disease is accelerated in hyperglycemic states. Vascular injury plays a pivotal role in the progression of atherosclerotic vascular disease in diabetes, which is characterized by increased vascular smooth muscle cell (VSMC) proliferation and extracellular matrix accumulation. We previously reported that diabetes alters the activity of the kallikrein-kinin system and results in the upregulation of kinin receptors in the vessel wall. To determine whether glucose can directly influence the regulation of kinin receptors, the independent effect of high glucose (25 mM) on B(2)-kinin receptors (B2KR) in VSMC was examined. A threefold increase in B2KR protein levels and a 40% increase in B2KR surface receptors were observed after treatment with high glucose after 24 h. The mRNA levels of B2KR were also significantly increased by high glucose as early as 4 h later. To elucidate the cellular mechanisms by which glucose regulates B2KR, we examined the role of protein kinase C (PKC). High glucose increased total PKC activity and resulted in the translocation of conventional PKC isoforms (beta(1) and beta(2)), novel (epsilon), and atypical (zeta) PKC isoforms into the membrane. Inhibition of PKC activity prevented the increase in B2KR levels induced by ambient high glucose. These findings provide the first evidence that glucose regulates the expression of B(2) receptors in VSMC and provide a rationale to further study the interaction between glucose and kinins on the pathogenesis of atherosclerotic vascular disease in diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247764     DOI: 10.1152/ajpheart.2001.280.4.H1537

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Matrix metalloproteinases modulated by protein kinase Cε mediate resistin-induced migration of human coronary artery smooth muscle cells.

Authors:  Qinxue Ding; Hong Chai; Nausheen Mahmood; Jerry Tsao; Daria Mochly-Rosen; Wei Zhou
Journal:  J Vasc Surg       Date:  2011-01-31       Impact factor: 4.268

2.  Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5.

Authors:  Dimitra Gkika; Catalin N Topala; Qing Chang; Nicolas Picard; Stéphanie Thébault; Pascal Houillier; Joost G J Hoenderop; René J M Bindels
Journal:  EMBO J       Date:  2006-09-28       Impact factor: 11.598

3.  Effect of chronic endothelin blockade on PKC isoform distribution in mesenteric arteries from diabetic rats.

Authors:  Jihong Jiang; Lili Zhang; Kathleen M Macleod; John H McNeill
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

4.  Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin-diabetic rat.

Authors:  Mohamed Abdouh; Ashraf Khanjari; Nadia Abdelazziz; Brice Ongali; Réjean Couture; Haroutioun M Hasséssian
Journal:  Br J Pharmacol       Date:  2003-09       Impact factor: 8.739

5.  Mechanisms of bradykinin-induced expression of connective tissue growth factor and nephrin in podocytes.

Authors:  J Abou Msallem; H Chalhoub; M Al-Hariri; L Saad; M A Jaffa; F N Ziyadeh; A A Jaffa
Journal:  Am J Physiol Renal Physiol       Date:  2015-10-07

Review 6.  The kallikrein-kinin system in diabetic nephropathy.

Authors:  Hirofumi Tomita; Ryan B Sanford; Oliver Smithies; Masao Kakoki
Journal:  Kidney Int       Date:  2012-02-08       Impact factor: 10.612

7.  Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes.

Authors:  Ying Cheng; Xiaochen Yu; Jie Zhang; Yunpeng Chang; Mei Xue; Xiaoyu Li; Yunhong Lu; Ting Li; Ziyu Meng; Long Su; Bei Sun; Liming Chen
Journal:  Diabetologia       Date:  2019-03-05       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.